Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

Similar articles for PubMed (Select 23125505)

1.

Exploratory study to evaluate tolerability, safety, and activity of Ashwagandha (Withania somnifera) in healthy volunteers.

Raut AA, Rege NN, Tadvi FM, Solanki PV, Kene KR, Shirolkar SG, Pandey SN, Vaidya RA, Vaidya AB.

J Ayurveda Integr Med. 2012 Jul;3(3):111-4. doi: 10.4103/0975-9476.100168.

2.

Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: ashwagandha.

Ven Murthy MR, Ranjekar PK, Ramassamy C, Deshpande M.

Cent Nerv Syst Agents Med Chem. 2010 Sep 1;10(3):238-46. Review.

PMID:
20528765
3.

Effects of Withania somnifera (Ashwagandha) and Terminalia arjuna (Arjuna) on physical performance and cardiorespiratory endurance in healthy young adults.

Sandhu JS, Shah B, Shenoy S, Chauhan S, Lavekar GS, Padhi MM.

Int J Ayurveda Res. 2010 Jul;1(3):144-9. doi: 10.4103/0974-7788.72485.

4.

Withania somnifera root extract improves catecholamines and physiological abnormalities seen in a Parkinson's disease model mouse.

RajaSankar S, Manivasagam T, Sankar V, Prakash S, Muthusamy R, Krishnamurti A, Surendran S.

J Ethnopharmacol. 2009 Sep 25;125(3):369-73. doi: 10.1016/j.jep.2009.08.003. Epub 2009 Aug 8.

PMID:
19666100
5.
6.

Clinical Evaluation of the Spermatogenic Activity of the Root Extract of Ashwagandha (Withania somnifera) in Oligospermic Males: A Pilot Study.

Ambiye VR, Langade D, Dongre S, Aptikar P, Kulkarni M, Dongre A.

Evid Based Complement Alternat Med. 2013;2013:571420. doi: 10.1155/2013/571420. Epub 2013 Nov 28.

7.

Safety, tolerance, and preliminary pharmacokinetics of nefazodone after administration of single and multiple oral doses to healthy adult male volunteers: a double-blind, phase I study.

Barbhaiya RH, Marathe PH, Greene DS, Mayol RF, Shukla UA, Gammans RR, Pittman KA, Robinson D.

J Clin Pharmacol. 1995 Oct;35(10):974-84.

PMID:
8568015
8.

Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects.

Sarashina A, Sesoko S, Nakashima M, Hayashi N, Taniguchi A, Horie Y, Graefe-Mody EU, Woerle HJ, Dugi KA.

Clin Ther. 2010 Jun;32(6):1188-204. doi: 10.1016/j.clinthera.2010.06.004.

PMID:
20637971
9.

Safety and pharmacokinetics of NXN-188 after single and multiple doses in five phase I, randomized, double-blind, parallel studies in healthy adult volunteers.

Vaughan D, Speed J, Medve R, Andrews JS.

Clin Ther. 2010 Jan;32(1):146-60. doi: 10.1016/j.clinthera.2010.01.006.

PMID:
20171420
10.

Phase I clinical studies of the advanced glycation end-product (AGE)-breaker TRC4186: safety, tolerability and pharmacokinetics in healthy subjects.

Chandra KP, Shiwalkar A, Kotecha J, Thakkar P, Srivastava A, Chauthaiwale V, Sharma SK, Cross MR, Dutt C.

Clin Drug Investig. 2009;29(9):559-75. doi: 10.2165/11315260-000000000-00000.

PMID:
19663519
12.

Bioavailability of two single-dose oral formulations of omeprazole 20 mg: an open-label, randomized sequence, two-period crossover comparison in healthy Mexican adult volunteers.

Poo JL, Galán JF, Rosete A, de Lago A, Oliva I, González-de la Parra M, Jiménez P, Burke-Fraga V, Namur S.

Clin Ther. 2008 Apr;30(4):693-9.

PMID:
18498918
13.
14.
15.

The effects of phytase and root hydroalcoholic extract of Withania somnifera on productive performance and bone mineralisation of laying hens in the late phase of production.

Tahmasbi AM, Mirakzehi MT, Hosseini SJ, Agah MJ, Fard MK.

Br Poult Sci. 2012;53(2):204-14. doi: 10.1080/00071668.2012.662628.

PMID:
22646786
16.

Pharmacokinetics, pharmacodynamics, and tolerability of a generic formulation of exenatide: a randomized, open-label, single- and multiple-dose study in healthy Chinese volunteers.

Shi S, Liu Y, Li Z, Wu J, Zhou X, Zeng F.

Arzneimittelforschung. 2012 Feb;62(2):75-82. doi: 10.1055/s-0031-1295484. Epub 2012 Feb 16.

PMID:
22344551
17.

Hypocholesteremic and antioxidant effects of Withania somnifera (Dunal) in hypercholesteremic rats.

Visavadiya NP, Narasimhacharya AV.

Phytomedicine. 2007 Feb;14(2-3):136-42. Epub 2006 May 18.

PMID:
16713218
18.

Effect of Withania somnifera root extract on haloperidol-induced catalepsy in albino mice.

Nair V, Arjuman A, Gopalakrishna HN, Nandini M.

Phytother Res. 2008 Feb;22(2):243-6.

PMID:
17886228
19.

Adaptogenic activity of Withania somnifera: an experimental study using a rat model of chronic stress.

Bhattacharya SK, Muruganandam AV.

Pharmacol Biochem Behav. 2003 Jun;75(3):547-55.

PMID:
12895672
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk